Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Ireland newsletter		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	israel@progress.im manually updating trust level from 1 to 5		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
Profile edited	Wed, 10/12/2022 - 13:23	Profile edited		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	slovenia@progress.im manually updating trust level from 1 to 5		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - PROGRESS IN MIND SLOVENIJA E-NOVICE		Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://za.progress.im/en		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Ireland newsletter		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	israel@progress.im manually updating trust level from 1 to 5		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
Profile edited	Wed, 10/12/2022 - 13:23	Profile edited		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	slovenia@progress.im manually updating trust level from 1 to 5		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - PROGRESS IN MIND SLOVENIJA E-NOVICE		Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER